Antibody Drug Conjugate

Share this animation:

This antibody drug conjugate was engineered to selectively deliver a cytotoxic agent to a tumor cell. It consits of an antibody made for a specific target molecule, a linker protein, and the cytotoxic agent.

Both the quality of the final product and my experience working with XVIVO has reinforced my interest in a long-term collaboration with this team.

Alain Viel PhD, Senior Lecturer and Director of Undergraduate Research in Molecular and Cellular Biology, Harvard University
Share this animation: